Effect of ibuprofen in treatment of congenital heart disease
Not Applicable
- Conditions
- Patent ductus arteriousus.Patent ductus arteriousus
- Registration Number
- IRCT2014112220029N1
- Lead Sponsor
- Vice chancellor for Research Of Shiraz University Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 33
Inclusion Criteria
Gestational age 37 weeks or more, age of after birth: 3 to 30 days, patent ductus arteriosus.
exclusion criteria: congenital heart disease dependent to patent ductus arteriosus, unable to feeding, bleeding tendency disorder, oliguria, creatinin more than 1.8 mg/dl.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Closure of dutus arteriosus. Timepoint: one day before intervention and one day after end of intervention. Method of measurement: Doppler Echocardiography Vivid 3 ultrasound machine GE vingmed, Horten, Norwey.
- Secondary Outcome Measures
Name Time Method Side effects like decrease urine output, gastrointestinal bleeding and discomfort, impaired renal function. Timepoint: one day before intervention, second day of intervention, one day after intervention. Method of measurement: clinical evaluation and check CBC, Creatinin , platelet, urine output.